Zai LabZLAB
NASDAQPharmaceuticals
No cached AI snapshot yet for ZLAB.
Be the first to run a multi-agent analysis on this ticker.
Key Stats
1,784 employees112.67M shares outstandinglisted 2017-09-20
Next earnings ~May 5, 2026
About Zai Lab
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
Latest News
Showing market-wide stock news
Why is Z.AI stock sliding today?
Why is Z.AI stock sliding today?
Euro: 1.150 target nears on Fed risk against US Dollar – ING
WTI falls near $100 as Saudi adds Oman route, US stocks surge
Yield on 10-year Treasury hovers above 5% as investors await Fed decision
Warsh’s Fed expected to hike rates 25bp as dot plot takes center stage
Related Stocksin Pharmaceuticals
Ready to see the live AI view on ZLAB?
Launch a real-time multi-agent room — Claude, GPT, Gemini, DeepSeek, Grok, and Qwen analyzing ZLAB side-by-side with live signals.